BioNTech (BNTX) net assets (shareholders' equity)

Net assets · fiscal 2025
€19.22B

BioNTech (BNTX) had net assets of €19.22B at the end of fiscal 2025 (December 31, 2025). That is 1.0% lower than the €19.41B of fiscal 2024. Figures as of 19 Nov 2026, 02:33 UTC, from Yahoo Finance.

Key facts

Net assets, fiscal 2025
€19.22B
Change on fiscal 2024
−1.0%
Highest on record
€20.25Bfiscal 2023
Lowest on record
€19.22Bfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

BioNTech net assets (shareholders' equity), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €20.25B in fiscal 2023 and the lowest €19.22B in fiscal 2025.

History · 4 fiscal years

Net assets by fiscal year

BioNTech net assets (shareholders' equity), year by year

BioNTech (BNTX) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025€19.22B 1.0% down
2024€19.41B 4.1% down
2023€20.25B 0.9% up
2022€20.06B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of BioNTech and comparable companies
CompanyNet assetsFiscal year
Viatris VTRS$14.71B2025
Tenet Healthcare THC$4.22B2025
BioNTech BNTX€19.22B2025
Guardant Health GH-$99.31M2025
Alnylam Pharmaceuticals ALNY$789.18M2025
Zimmer Biomet Holdings ZBH$12.70B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BNTX

BioNTech, figure by figure

BioNTech (BNTX) overview: price, valuation and scorecardAll health care companies by market value

BioNTech net assets (shareholders' equity): questions and answers

What are BioNTech's net assets?

BioNTech (BNTX) had net assets of €19.22B at the end of fiscal 2025 (December 31, 2025). That is 1.0% lower than the €19.41B of fiscal 2024.

What are the highest and lowest net assets figures on record for BioNTech?

Across the 4 fiscal years on record (2022–2025), the highest was €20.25B in fiscal 2023 and the lowest €19.22B in fiscal 2025.

How is BioNTech's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For BioNTech it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BioNTech (BNTX) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/BNTX/net-assets

Underlying data: Yahoo Finance.